Objective: The objective of this study was to compare outcomes after videoassisted thoracoscopic lobectomy or segmentectomy before and after introduction of an enhanced recovery program.
The enhanced recovery pathway (ERP) is a multimodal, evidence-based bundles of interventions aimed at hastening postoperative recovery, reducing complications, shortening hospital stay, and improving patient experience.
The ERP is based on the concept of ''marginal gains,'' based on the standardized application of multiple elements covering all aspects of perioperative care. These elements 1 The ERP has been popularized in colorectal surgery, where it has shown the greatest benefit compared with standard care, and has been shown to improve outcomes in almost all major surgical specialties. 2, 3 However, in thoracic surgery, there is limited and generally lowquality evidence regarding the influence of the ERP on outcome. A recent systematic review identified 6 studies, of which only 1 was a randomized trial. This review found that the ERP in elective lung surgery was associated with shorter hospital stay but similar complication, mortality, and readmission rates compared with standard care. 4 In contrast to the ERP in colorectal surgery, many elements of the ERP are routinely used in thoracic surgery and are well embedded in practice as standard care (eg, fluid restriction, early mobilization, rehabilitation, early as possible enteral feeding, and the approach to pain management). Therefore, the ERP in thoracic surgery may not be dissimilar enough from standard care to improve the outcome. 5 Furthermore, most of the studies dealing with the ERP in thoracic surgery did not include patients undergoing videoassisted thoracoscopic surgery (VATS) or were conducted before the widespread use of this approach. [6] [7] [8] [9] Minimally invasive surgery is a key element of the ERP in other specialties. 10 VATS has been shown to reduce complications and shorten hospital stay after lung resection [11] [12] [13] and conceptually seems to be the ideal surgical approach in the context of the ERP to improve the outcome. However, there is no study specifically analyzing whether the application of the ERP in the context of minimally invasive thoracic surgery would provide outcome benefits compared with standard care. A recent systematic review 4 acknowledged this knowledge gap and concluded that future research is needed to investigate this aspect.
A formal ERP recently has been implemented for patients undergoing lung resection for lung cancer in our unit. The majority underwent VATS resection. Therefore, the purpose of this analysis was to assess the impact of the ERP on the outcome of patients undergoing VATS lobectomy compared with similar patients undergoing operation before the start of the ERP in our unit.
PATIENTS AND METHODS
This is a retrospective analysis performed on a prospectively maintained quality-improvement institutional database. The analysis included 600 patients undergoing VATS lobectomy (561) or VATS anatomic segmentectomies (39) between April 2014 and January 2017. These patients represent 85% of all lobectomies and segmentectomies performed at St James's University Hospital during this time period (15% were performed through an open approach and were not included in this analysis). Sixty-seven patients whose surgery commenced via a VATS approach but who subsequently underwent conversion to open surgery for oncologic, anatomic, or technical reasons or because of intraoperative complications were included in the analysis.
The study was reviewed by the Research and Innovation Department of our hospital, which waived National Health Service Research Ethics Committee review and classified it as a service evaluation. Patients were selected for operation according to current functional guidelines.
14 All operations were undertaken by board-certified thoracic surgeons using a 2-to 3-port VATS anterior approach. All patients were extubated in the operating room and transferred to a level 2 care unit (thoracic intermediate care unit) for monitoring. On the morning of the first postoperative day (day 1), patients were stepped down to a dedicated thoracic surgery ward unless clinically contraindicated.
An ERP was implemented in our unit in January 2016. For the purpose of auditing the results of the ERP, we allowed a 1-month washout period to ensure that all elements of the ERP were fully implemented and adherence to the protocol was optimized. From February 2016 to January 2017, 235 patients underwent VATS lobectomy and were managed according to the ERP program.
Elements of care that were already part of standard care before the introduction of the ERP include the following:
Multimodal analgesia. A variable regimen for postoperative analgesia achieved with a combination of systemic (intravenous) opioid (via a patient-controlled analgesia system) and paravertebral analgesia using a 0.5% bupivacaine bolus followed by 0.25% bupivacaine postoperative infusion. Delivery of analgesia is titrated to achieve numeric pain score lower than 3 on a scale of 0 (no pain) to 10 (excruciating pain). Mobilization. All patients are mobilized as early as possible, most frequently on postoperative day 1 (the morning after surgery). They receive postoperative chest physiotherapy and physical rehabilitation. Chest drain management. All patients undergoing VATS are managed by 1 chest drain connected to a digital chest drainage system. Chest drains are removed as soon as possible when the drain output in a 24-hour period is less than 400 mL and air flow is less than 20 mL per minute for more than 6 hours without an air leak spikes. Other interventions include antibiotic prophylaxis (at anesthetic induction and 2 doses postoperatively); minimally invasive (VATS) surgery, use of short-acting anesthetic agents; use of nerve or paravertebral blocks as part of multimodal analgesia; avoidance of fluid overload and postoperative information provided at discharge and a telephone follow-up performed at 3 and 7 days postoperatively.
With the introduction of the ERP in January 2016, new elements of care were added. The newly introduced elements are shown in detail in Table 1 . Major new components included the following:
The development of a new patient information program. This is a perioperative ERP-focused education session for patients, which they are encouraged to attend. An explanation of the elements of the ERP is given, and the concept of the active role of the patient is introduced. At this session, patients receive a written information package and a patient diary. Before the ERP, an education session did take place but without an ERP focus and without a theme of active patient involvement. Incentive spirometry, including written instructions on its use to commence before surgery and to continue into the postoperative period. Preoperative carbohydrate loading. Preoperative warming commencing 45 minutes before surgery. Motivational talks given by the ERP nurse both preoperatively and on each postoperative inpatient day.
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Early postoperative return to oral intake including regular nutritional supplement drinks. Prevention of nausea and vomiting by regular administration of antiemetic drugs.
Adherence to the program was monitored by a dedicated ERP nurse assisted by the ward nurses. All patients received all the elements that were provided by the staff, for example, attendance at the patient information program, preoperative drinks, incentive spirometer, preoperative warming, offers of preoperative oral fluids, and a prescription for all the required medications. We did not record individual patient uptake of those elements about which the patients have choice, for example, if all the preoperative drinks were consumed, how often the incentive spirometer was used, the number of doses of pro re nata analgesics required, and so forth.
Statistical Analysis
Patients managed according to the ERP were compared with those managed before the introduction of the ERP. To rule out overlapping of management between periods, we excluded from the analysis those patients operated on during the first month of ERP implementation (washout period). After 1 month, all elements of the ERP were fully implemented and adherence to the program was optimized. The main end points were in-hospital or 30-day mortality, 90-day mortality, cardiovascular and pulmonary complications occurring during the hospitalization or within 30 days from operation, postoperative length of stay, and readmission rate within 30 or 90 days from operation.
For the purpose of this study, pulmonary complications include respiratory failure (reintubation at any time after operation or assisted mechanical ventilation for>24 hours), acute respiratory distress syndrome, pulmonary The normal distribution of numeric variables was first assessed by the Shapiro-Wilk normality test. Numeric variables with normal distribution were tested by the unpaired Student t test, and those without normal distribution were tested by the Mann-Whitney test. Categoric variables were tested by the chi-square test or, if the observations in at least 1 cell were less than 10, the Fisher exact test.
No variable had more than 5% incomplete data. Missing variables were imputed by using multiple imputation techniques.
To adjust for confounders, we developed risk-adjusting models to estimate cardiopulmonary morbidity and 30-day mortality. Several variables were tested for a possible association with these 2 outcomes by stepwise logistic regression analyses (age, sex, body mass index, forced expiratory volume in 1 second, carbon monoxide lung diffusion capacity, presence of underlying coronary artery disease, cerebrovascular disease, diabetes, performance score, duration of surgery). The regression analyses generated regression equations that were used to estimate the expected outcomes for each period (pre-ERP and ERP).
The following logit equation was used to calculate predicted cardiopulmonary morbidity:
The following logit equation was used to calculate predicted 30-day mortality:
À2:566 À 0:0446XDLCO þ 0:563XCAD þ 0:0116Xoperation time
The risk-adjusted postoperative cardiopulmonary morbidity or mortality rates were then calculated in each group by using the following equation: (observed postoperative outcome/predicted postoperative outcome) 3 average observed postoperative outcome of the overall population. The risk-adjusted postoperative outcome is the outcome, which is expected to be associated with that period (ERP or pre-ERP) if the case mix in that group was similar to the average case mix characteristics of the overall population in the study. The statistical tests were performed on the statistical software Stata 12.0 (StataCorp, LP, College Station, Tex). Table 2 shows the baseline and surgical characteristics of the patients undergoing operation before and after the start of the ERP. The 2 groups had similar characteristics with the exception of a higher incidence of coronary artery disease (22% vs 15%, P ¼ .03) and a lower proportion of patients with a performance status greater than 1 in the ERP group (4.7% vs 9.1%, P ¼ .05) compared with the pre-ERP one. Table 3 summarizes the results of the comparison of outcomes between patients operated before and after ERP. The 2 groups had a similar postoperative length of stay (ERP median 5 days; interquartile range, 3-7 vs pre-ERP 4; interquartile range, 3-7, P ¼ .44). A similar number of patients in the 2 groups failed to meet the target of 5 days postoperative hospital stay only (ERP 41% vs pre-ERP 35%, P ¼ .15).
RESULTS
No differences were found in the incidence of cardiovascular and pulmonary complications (ERP 22.6% vs pre-ERP 22.4%, P ¼ .98) or pure pulmonary complications (ERP 17.9% vs pre-ERP 16.7%, P ¼ .71) between the groups.
In-hospital or 30-day mortality occurred in 9 patients of the ERP (3.8%) and in 8 patients of the pre-ERP group (2.2%) (P ¼ .31). Ninety-day mortality rates also were similar between the 2 groups (ERP 4.7% vs pre-ERP 3.0%, P ¼ .37).
Finally, no differences were noted in terms of 30-day (ERP 7.2% vs pre-ERP 7.4%, P ¼ .94) or 90-day readmission rates (ERP 9.8% vs pre-ERP 12.3%, P ¼ .34).
Because postoperative morbidity and mortality may be influenced by patient-and surgical-related characteristics, we constructed regression models to adjust the outcomes for these confounders. These models were then used to calculate risk adjusted morbidity and mortality in each group (see ''Patients and Methods'').
The risk-adjusted cardiopulmonary morbidity rates were similar in the 2 periods (ERP 21.9% vs pre-ERP 22.9%, z test P ¼ .76), whereas the risk-adjusted 30-day mortality was higher in the ERP period compared with the pre-ERP one (3.6% vs 2.3%, z test P ¼ .0004). 
DISCUSSION

Main Findings
In our specialty, there is limited evidence regarding the effectiveness of the ERP on outcome. In particular, there is no study specifically focusing on the application of the ERP in the context of minimally invasive thoracic surgery, which is by definition one of the main elements of the ERP. Therefore, we set up this retrospective analysis to compare the outcomes after VATS lobectomy before and after the start of the ERP in our institution. We were not able to find differences in incidence of cardiopulmonary complications, 30-day or 90-day mortality rates, length of postoperative stay, and hospital readmission within 30 or 90 days from the operation between the groups. Extrapolation of our findings to the wider thoracic surgery community is limited because our data are a snapshot of a clinical practice and represent outcomes from a single thoracic center. However, our unit undertakes approximately 300 lung resection operations per year and has a high rate (75%) of resection via the VATS approach. VATS is a recent development in lung resection surgery and may now be regarded as the recommended approach for early-stage lung cancer. 16 Our findings suggest that all components of an ERP may not be necessary for patients undergoing VATS resection. An ERP inevitably increases cost; the introduction of patient diaries, incentive spirometry, carbohydrate loading, preoperative warming, nutritional supplements, and use of a dedicated ERP nurse cost $189.0 per patient in our unit in 2016. In the absence of demonstrable benefit for patients, this extra cost is hard to justify in a modern healthcare system under financial strain.
There are 2 potential explanations of our findings. First, it is possible that our ERP interventions were insufficient to produce a measurable benefit. As can be seen in Table 1 , there were several differences in perioperative care when comparing the pre-ERP and ERP patient groups, but also some elements common to both groups. Some of the common elements may be missing components from a traditional ERP, for example, use of epidural analgesia to avoid systemic opiates or use of goal-directed therapy to avoid fluid overload. However, we believe a more likely explanation is that the pre-ERP standard care already involved sufficient ERP components 5 to provide patients undergoing VATS with good outcomes, for example, the preoperative information and health advice, antibiotic prophylaxis, minimally invasive surgery, single chest drain, digital drainage system, and multimodal analgesia, although variable. Identifying which ERP components are the most useful is challenging, and the literature does not provide answers. A large metaanalysis of ERP in various specialties was not able to identify any significantly beneficial individual components, 2 and indeed the key to the success of any ERP may well be the synergistic effect of all elements being applied together by a unit used to managing patients in this way.
Second, VATS lung resection may be sufficiently noninvasive, low risk, and typically associated with uncomplicated recovery that the ERP is simply not required. The clinical experience of surgeons and anesthetists suggests that patients who have more major and high-risk surgical procedures, with the associated physiologic disturbances and stress responses to surgery, have poorer outcomes and so may need additional interventions in the perioperative period to help them overcome these challenges. The literature on the ERP does not support this view: Different surgical specialties have not been found to derive different degrees of benefit from the ERP. 2 One study of patients undergoing VATS resection found a significant difference in the length of stay for patients before and after introduction of an ERP, 17 but in this study the length of stay was very long (29 and 19 days in the 2 groups, respectively), suggesting that the patients differed significantly from our cohort (5 and 5 days, respectively). Thus, there is no current evidence to contest our findings that patients undergoing VATS do not benefit from or require the ERP.
Study Limitations
First, our analysis focused on a population of patients undergoing minimally invasive thoracic surgery. Generalizability of the results to patients undergoing open surgery Moreover, the results generated by this study may not be applicable in units in which most of the ERP elements are not included in their standard care, as occurred in our setting. The implementation of ERP may be more beneficial and cost-effective in these institutions even for patients undergoing VATS.
Second, we reported only objective outcomes (morbidity and mortality). Patient-reported outcomes such as quality of life or patient satisfaction with care were not routinely collected in this group of patients. These are certainly additional end points requiring investigation in the future to evaluate the true success of ERP in this patient group. Although the inclusion of multiple ERP elements in the perioperative care of patients undergoing VATS did not provide any clinical advantage in terms of morbidity or mortality in our unit, we cannot rule out that those elements may have improved the overall patient experience with care compared with the pre-ERP period.
Another possible limitation is the relatively shorter ERP period compared with the pre-ERP period. Especially if adherence to the program was slow at the beginning, this may introduce a bias against ERP because of overlapping of pathways of care. To minimize this problem, we excluded those patients managed during the first month of ERP implementation (washout period). Because most of the ERP elements were already part of our standard care, this period was sufficient to fully implement ERP in our setting with optimal adherence to the program as shown in Table 1 .
Finally, this is not a randomized study, and inherent problems of cohort selection may be present as in all retrospective investigations. We chose not to use balancing score and case matching in this context because the only variable that would affect the propensity of the patients to receive either intervention (ie, ERP or non-ERP) is whether they underwent their surgery before or after January 2016. The 2 groups were substantially similar in terms of baseline and surgical characteristics because patient selection criteria for surgery did not change during the relatively short study period. In any case, we used logistic regression analysis to adjust for the effect of other confounders and verify the independent influence of ERP on the outcomes.
CONCLUSIONS
For patients undergoing VATS lung resection, we may now be in a ''post-ERP'' world. It is possible that sufficient beneficial components of ERP are now received by all patients and that this should now be regarded as ''standard'' rather than ''enhanced'' care. Will it ever be possible to demonstrate outcome benefits to justify the extra cost of ERP for these patients? Progress in medical care, as in sports, is now mostly achieved by ''aggregation of marginal gains,'' in which numerous small modifications result in improved outcome. If this proves to be the case for perioperative care bundles such as ERP, then the research needed to tease apart the marginal gains from so many small interventions in such diverse surgical procedures will be extremely challenging, and perhaps impossible. Future studies will be needed to confirm our findings in other centers with a different case mix of patients, different distribution of minimally invasive surgery, and different standard care pathways.
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